chr2-219210752-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PP3_ModerateBS1_SupportingBS2
The NM_005689.4(ABCB6):c.2215C>T(p.Arg739Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000324 in 1,613,730 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R739H) has been classified as Uncertain significance.
Frequency
Consequence
NM_005689.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABCB6 | NM_005689.4 | c.2215C>T | p.Arg739Cys | missense_variant | 16/19 | ENST00000265316.9 | |
ABCB6 | NM_001349828.2 | c.2077C>T | p.Arg693Cys | missense_variant | 15/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABCB6 | ENST00000265316.9 | c.2215C>T | p.Arg739Cys | missense_variant | 16/19 | 1 | NM_005689.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000424 AC: 105AN: 247698Hom.: 0 AF XY: 0.000380 AC XY: 51AN XY: 134336
GnomAD4 exome AF: 0.000327 AC: 478AN: 1461494Hom.: 2 Cov.: 32 AF XY: 0.000336 AC XY: 244AN XY: 727012
GnomAD4 genome AF: 0.000296 AC: 45AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74430
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 23, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 16, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 739 of the ABCB6 protein (p.Arg739Cys). This variant is present in population databases (rs141840760, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with ABCB6-related conditions. ClinVar contains an entry for this variant (Variation ID: 993667). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Microphthalmia, isolated, with coloboma 7 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Dr. Zeinali's Medical Genetics Lab, Kawsar Human Genetics Research Center | Mar 12, 2024 | - - |
ABCB6-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 11, 2023 | The ABCB6 c.2215C>T variant is predicted to result in the amino acid substitution p.Arg739Cys. This variant has been reported along with two variants in the SPTA1 gene in an individual with an erythrocyte disorder (Andolfo et al. 2021. PubMed ID: 34201899). This variant is reported in 0.11% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-220075474-G-A), which may be too common to be a primary cause of disease. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at